MA28337A1 - Derives de l'acide 7-phenylamino-4-quinolone-3-carboxylique, methodes pour leur production et leur utilisation en tant que medicaments - Google Patents

Derives de l'acide 7-phenylamino-4-quinolone-3-carboxylique, methodes pour leur production et leur utilisation en tant que medicaments

Info

Publication number: MA28337A1
Authority: MA; Morocco
Prior art keywords: quinolone; phenylamino; medicaments; production; methods
Prior art date: 2004-01-31

Application number

MA29216A

Other languages

English (en)

Inventor

Elisabeth Defossa

Dieter Kadereit

Sven Ruf

Thomas Klabunde

Dieter Schmoll

Andreas Herling

Karl-Ulrich Wendt

Original Assignee

Sanofi Aventis Deutschland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-01-31

Filing date

2006-07-28

Publication date

2006-12-01

2004-01-31 Priority claimed from DE102004004973A external-priority patent/DE102004004973A1/de

2004-07-10 Priority claimed from DE102004033405A external-priority patent/DE102004033405A1/de

2006-07-28 Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland

2006-12-01 Publication of MA28337A1 publication Critical patent/MA28337A1/fr

Links

UANVNDSRTZUBNX-UHFFFAOYSA-N 7-anilino-4-oxo-3h-quinoline-3-carboxylic acid Chemical class C=1C=C2C(=O)C(C(=O)O)C=NC2=CC=1NC1=CC=CC=C1 UANVNDSRTZUBNX-UHFFFAOYSA-N 0.000 title 1
239000003814 drug Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/60—Quinoline or hydrogenated quinoline ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Diabetes (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Quinoline Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

MA29216A 2004-01-31 2006-07-28 Derives de l'acide 7-phenylamino-4-quinolone-3-carboxylique, methodes pour leur production et leur utilisation en tant que medicaments MA28337A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102004004973A DE102004004973A1 (de)	2004-01-31	2004-01-31	7-Phenylamino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE102004033405A DE102004033405A1 (de)	2004-07-10	2004-07-10	7-Phenylamino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number	Publication Date
MA28337A1 true MA28337A1 (fr)	2006-12-01

Family

ID=34828328

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA29216A MA28337A1 (fr)	2004-01-31	2006-07-28	Derives de l'acide 7-phenylamino-4-quinolone-3-carboxylique, methodes pour leur production et leur utilisation en tant que medicaments

Country Status (19)

Country	Link
EP (1)	EP1713803B1 (fr)
JP (1)	JP2007519648A (fr)
KR (1)	KR20060132671A (fr)
AR (1)	AR047516A1 (fr)
AT (1)	ATE438645T1 (fr)
AU (1)	AU2005209365A1 (fr)
BR (1)	BRPI0507309A (fr)
CA (1)	CA2554522A1 (fr)
DE (1)	DE502005007840D1 (fr)
EC (1)	ECSP066734A (fr)
IL (1)	IL176913A0 (fr)
MA (1)	MA28337A1 (fr)
OA (1)	OA13364A (fr)
PA (1)	PA8622401A1 (fr)
PE (1)	PE20051094A1 (fr)
RU (1)	RU2006131306A (fr)
TW (1)	TW200533353A (fr)
UY (1)	UY28732A1 (fr)
WO (1)	WO2005073229A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1881974A4 (fr) *	2005-04-21	2011-03-16	Targanta Therapeutics Inc	Fluoroquinolones phosphonees, leurs analogues antibacteriens, et methodes permettant de prevenir et de traiter des infections osseuses et articulaires
CA2624102A1 (fr)	2005-09-29	2007-04-12	Sanofi-Aventis	Derives de phenyl-1,2,4-oxadiazolone : procedes de preparation et utilisation comme produits pharmaceutiques
PE20080251A1 (es)	2006-05-04	2008-04-25	Boehringer Ingelheim Int	Usos de inhibidores de dpp iv
EP2061767B1 (fr)	2006-08-08	2014-12-17	Sanofi	Imidazolidin-2,4-diones arylaminoaryl-alkyl-substituées, procédé de fabrication, médicaments les contenant et leur utilisation
NZ576036A (en)	2006-10-16	2010-10-29	Bionomics Ltd	Naphthyridine containing compounds for treating anxiety disorders
US10954231B2 (en)	2006-10-16	2021-03-23	Bionomics Limited	Anxiolytic compounds
DE102007005045B4 (de)	2007-01-26	2008-12-18	Sanofi-Aventis	Phenothiazin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP2025674A1 (fr)	2007-08-15	2009-02-18	sanofi-aventis	Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament
UY31968A (es)	2008-07-09	2010-01-29	Sanofi Aventis	Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
WO2010073078A2 (fr) *	2008-12-22	2010-07-01	Orchid Research Laboratories Ltd.	Composés hétérocycliques comme inhibiteurs de hdac
WO2011107494A1 (fr)	2010-03-03	2011-09-09	Sanofi	Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation
EP2582709B1 (fr)	2010-06-18	2018-01-24	Sanofi	Dérivés d'azolopyridin-3-one en tant qu'inhibiteurs de lipases et de phospholipases
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
US9023848B2 (en)	2011-03-02	2015-05-05	Bionomics Limited	Small-molecules as therapeutics
WO2012120056A1 (fr)	2011-03-08	2012-09-13	Sanofi	Dérivés oxathiazine tétra-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
WO2012120051A1 (fr)	2011-03-08	2012-09-13	Sanofi	Dérivés benzyl-oxathiazine substitués avec adamantane ou noradamantane, médicaments contenant ces composés et leur utilisation
EP2683704B1 (fr)	2011-03-08	2014-12-17	Sanofi	Dérivés oxathiazine ramifiés, procédé pour leur préparation, utilisation en tant que médicament, agents pharmaceutiques contenant ces dérivés et leur utilisation
US8895547B2 (en)	2011-03-08	2014-11-25	Sanofi	Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
EP2683699B1 (fr)	2011-03-08	2015-06-24	Sanofi	Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
US8828994B2 (en)	2011-03-08	2014-09-09	Sanofi	Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120058A1 (fr)	2011-03-08	2012-09-13	Sanofi	Dérivés d'oxathiazine substitués par des groupes benzyle ou hétérométhylène, leur procédé de production, leur utilisation comme médicament ainsi que produits pharmaceutiques les contenant et leur utilisation
EP2766349B1 (fr)	2011-03-08	2016-06-01	Sanofi	Dérivés d'oxathiazine substitués par des carbocycles ou des hétérocycles, leur procédé de préparation, médicaments contenant ces composés et leur utilisation
EP2683702B1 (fr)	2011-03-08	2014-12-24	Sanofi	Nouveaux dérivés de phényle-oxathiazine substitués, leur procédé de fabrication, médicament contenant ces liaisons et son utilisation
EP2707367B1 (fr)	2011-05-12	2019-10-09	Bionomics Limited	Procédés pour la préparation de naphtyridines
WO2013037390A1 (fr)	2011-09-12	2013-03-21	Sanofi	Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
EP2567959B1 (fr)	2011-09-12	2014-04-16	Sanofi	Dérivés d'amide d'acide 6-(4-hydroxy-phényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
WO2013045413A1 (fr)	2011-09-27	2013-04-04	Sanofi	Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b] pyridine-4-carboxylique utilisés comme inhibiteurs de kinase
AU2019318209B2 (en)	2018-08-10	2025-09-25	Diapin Therapeutics, Llc	Tri-peptides and treatment of metabolic, cardiovascular and inflammatory disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0205165D0 (en) *	2002-03-06	2002-04-17	Astrazeneca Ab	Chemical compounds

2005
- 2005-01-15 AU AU2005209365A patent/AU2005209365A1/en not_active Abandoned
- 2005-01-15 KR KR1020067015355A patent/KR20060132671A/ko not_active Withdrawn
- 2005-01-15 WO PCT/EP2005/000363 patent/WO2005073229A1/fr not_active Ceased
- 2005-01-15 JP JP2006549988A patent/JP2007519648A/ja not_active Abandoned
- 2005-01-15 DE DE502005007840T patent/DE502005007840D1/de not_active Expired - Lifetime
- 2005-01-15 AT AT05700953T patent/ATE438645T1/de not_active IP Right Cessation
- 2005-01-15 CA CA002554522A patent/CA2554522A1/fr not_active Abandoned
- 2005-01-15 OA OA1200600243A patent/OA13364A/en unknown
- 2005-01-15 RU RU2006131306/04A patent/RU2006131306A/ru unknown
- 2005-01-15 BR BRPI0507309-0A patent/BRPI0507309A/pt not_active Application Discontinuation
- 2005-01-15 EP EP05700953A patent/EP1713803B1/fr not_active Expired - Lifetime
- 2005-01-27 TW TW094102386A patent/TW200533353A/zh unknown
- 2005-01-28 AR ARP050100321A patent/AR047516A1/es unknown
- 2005-01-28 PE PE2005000109A patent/PE20051094A1/es not_active Application Discontinuation
- 2005-01-31 PA PA20058622401A patent/PA8622401A1/es unknown
- 2005-01-31 UY UY28732A patent/UY28732A1/es unknown
2006
- 2006-07-17 IL IL176913A patent/IL176913A0/en unknown
- 2006-07-28 EC EC2006006734A patent/ECSP066734A/es unknown
- 2006-07-28 MA MA29216A patent/MA28337A1/fr unknown

Also Published As

Publication number	Publication date
EP1713803B1 (fr)	2009-08-05
ATE438645T1 (de)	2009-08-15
DE502005007840D1 (de)	2009-09-17
TW200533353A (en)	2005-10-16
CA2554522A1 (fr)	2005-08-11
IL176913A0 (en)	2006-12-10
UY28732A1 (es)	2005-08-31
AU2005209365A1 (en)	2005-08-11
KR20060132671A (ko)	2006-12-21
OA13364A (en)	2007-04-13
PE20051094A1 (es)	2006-02-07
ECSP066734A (es)	2006-10-31
AR047516A1 (es)	2006-01-25
BRPI0507309A (pt)	2007-06-26
JP2007519648A (ja)	2007-07-19
WO2005073229A1 (fr)	2005-08-11
PA8622401A1 (es)	2005-08-10
EP1713803A1 (fr)	2006-10-25
RU2006131306A (ru)	2008-03-10

Publication	Publication Date	Title
MA28337A1 (fr)	2006-12-01	Derives de l'acide 7-phenylamino-4-quinolone-3-carboxylique, methodes pour leur production et leur utilisation en tant que medicaments
MA27366A1 (fr)	2005-06-01	Nouveaux derives de thiophenylglycoside, methodes pour leur production, medicaments contenant lesdits composes et leur utilisation
CY2014042I1 (el)	2015-12-09	Γλυκοπυρανοζυλο-υποκατεστημενα παραγωγα βενζολιου, φαρμακα που περιεχουν τις ενωσεις αυτες, χρηση αυτων και μεθοδος για την παραγωγη τους
ATE460401T1 (de)	2010-03-15	1,2,4,5-tetrahydro-3h-benzazepinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
EP1773768A4 (fr)	2008-08-06	Derives de pyrrole en tant qu'agents pharmaceutiques
ATE441638T1 (de)	2009-09-15	4,5-diphenyl-pyrimidinyl substituierte carbonsäuren, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE502005009723D1 (de)	2010-07-22	Arylsubstituierte heterozyklen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE388944T1 (de)	2008-03-15	Indanessigsäure-derivate und ihre verwendung als pharmazeutische mittel, zwischenprodukten und verfahren zur herstellung
DK1660431T3 (da)	2009-06-15	Phenoxyeddikesyrederivater
MA28600B1 (fr)	2007-05-02	Dérivés de dioxyde d'oxazolobenzoisothiazole substitués, procédé de production et utilisation de ceux-ci
EP1931369A4 (fr)	2012-05-02	Methodes permettant de reduire l'expression de cd36
WO2009071689A3 (fr)	2009-07-23	Dérivés d'oxindole substitués par halogène en position 5 et leur utilisation pour traiter des maladies liées à la vasopressine
DE60304599D1 (de)	2006-05-24	Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE502007005902D1 (de)	2011-01-20	-methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
CR10953A (es)	2009-09-09	Nuevos derivados triciclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
ATE337317T1 (de)	2006-09-15	Imidazopyrin-derivate, verfahren zu ihrer herstellung and sie enthaltende pharmazeutische zusamensetzungen
EP1988090A4 (fr)	2010-06-30	Dérivés d'acide imidazol-5-carboxylique, leurs procédés de préparation et leur utilisation
DE502005001841D1 (de)	2007-12-13	Verfahren zur herstellung von 1,4-diphenylazetidinon-derivaten
DE602005014280D1 (de)	2009-06-10	Verfahren zur herstellung von ä1,4,5ü-oxadiazepinderivaten
CY2011018I1 (el)	2016-12-14	Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος
ATE372992T1 (de)	2007-09-15	Indanyl-piperazinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
NO20084860L (no)	2009-01-08	Stabile farmasøytiske preparater av 2-aza-bisyklo-[3,3,0]-oktan-3-karboksylsyrederivater
EP1915369A4 (fr)	2010-09-08	Nouveau 1,2,3-t ii azolylméthyle-benzothiophène substitués ou -indole et leur utilisation en tant qu'inhibiteurs de biosynthèse leukotiiène
ATE424823T1 (de)	2009-03-15	4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin- derivate als arzneimittel zur behandlung von unfruchtbarkeit
ATE466863T1 (de)	2010-05-15	Neue aminopyrrolo-ä1,2-aü-indol- und aminopyridazino-ä1,6-aü-indol-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen damit